Save 35% + Free Shipping — Single Vials In Stock · code

Back to Catalog

Peptides

BPC-157 5 mg

$139Per Unit

Cold-chain distribution ready vials maintained under Chicago fulfillment hub protocols. Single-vial and bulk research orders available.

Batch B2025-04B · COA on request
Lyophilized peptide
2–8°C

1 × $139.00 = $139.00 $90.35 (35% off with code EHAB35 + free shipping)

Your single-vial order qualifies: apply code EHAB35 at checkout for 35% off and free shipping.

BPC-157 5 mg

$90.35 · 35% off

Research use only
BPC-157 5 mg research packaging
Lyophilized peptide
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Batch B2025-04B) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

BPC-157(Body Protection Compound-157, pentadecapeptide BPC 157)

Regulatory status
Not approved by the FDA for any use. FDA lists BPC-157 among substances that may present significant safety risks in compounding, citing possible immunogenicity and impurity concerns.
Strongest evidence
Mostly animal studies; human data limited to two small uncontrolled reports
Overview

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence found in a gastric protein. It is widely discussed for tissue repair, but almost all published evidence comes from animal and cell studies.

What researchers study it for
  • Tendon, ligament, muscle and bone healing (animal models)
  • Gastrointestinal injury models
  • Wound healing models
Mechanism

Reviews describe effects on angiogenesis (new blood-vessel growth), growth-hormone receptor expression and inflammatory cytokines in preclinical models. These mechanisms have not been confirmed in humans.

Evidence (5)
  1. Review

    Systematic review (HSS Journal, 2025)

    Of 36 eligible studies (1993-2024), 35 were preclinical and 1 was clinical. Preclinical models showed improved structural and biomechanical healing of muscle, tendon, ligament and bone. The authors found no clinical safety data.[1]

  2. Animal study

    Rat Achilles tendon (J Orthop Res, 2003)

    Faster healing of transected rat Achilles tendons; the same paper reports stimulated tendon-cell growth in culture.[2]

  3. Cells / in vitro

    Tendon fibroblasts (J Appl Physiol, 2011)

    Promoted outgrowth, survival and migration of tendon fibroblasts.[3]

  4. Human · small / uncontrolled

    Small human reports (2021, 2024)

    A retrospective phone survey of 16 knee-pain patients and a 12-patient pilot in interstitial cystitis, both from one private clinic, without control groups. Uncontrolled reports like these cannot separate a real effect from placebo or natural recovery.[4][5]

  5. Regulatory

    FDA compounding risk list

    Listed by FDA as a bulk substance that may present significant safety risks in compounding.[6]

Limitations of the evidence
  • No randomized human trial has been published.
  • A large share of the literature comes from a single research group; independent replication is limited.
  • Its use is prohibited in professional sport.
  • Human oral bioavailability of the capsule form is not established.
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Questions researchers ask
Has BPC-157 been tested in people?
Only in two small, uncontrolled reports. A 2025 systematic review found no clinical safety data.
Why is it everywhere online, then?
Animal results are striking and widely shared. Reddit and forum reports are anecdotes: they are interesting context, not evidence of effect or safety.
Sources (7)
  1. 1.Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewVasireddi N et al. HSS J. 2025 Review
  2. 2.Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growthStaresinic M et al. J Orthop Res. 2003 Animal study
  3. 3.The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migrationChang CH et al. J Appl Physiol. 2011 Cells / in vitro
  4. 4.Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee E, Padgett B. Altern Ther Health Med. 2021 Human · small / uncontrolled
  5. 5.Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot StudyLee E et al. Altern Ther Health Med. 2024 Human · small / uncontrolled
  6. 6.Certain bulk drug substances for use in compounding that may present significant safety risks (lists BPC-157)U.S. FDA, page current as of Apr 22, 2026 Regulatory
  7. 7.Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceMendias CL, Awan TM. Sports Med. 2026 Review
Every published studyPubMed search: BPC-157(opens in a new tab)Every registered trialClinicalTrials.gov search: BPC-157(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.